These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7836050)

  • 1. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First recorded outbreaks of meningococcal disease in the Israel Defence Force: three clusters due to serogroup C and the emergence of resistance to rifampicin.
    Almog R; Block C; Gdalevich M; Lev B; Wiener M; Ashkenazi S
    Infection; 1994; 22(2):69-71. PubMed ID: 8070932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive effect of meningococcal vaccination in Israeli military recruits.
    Mimouni D; Bar-Zeev Y; Huerta M; Balicer RD; Grotto I; Ankol O
    Am J Infect Control; 2010 Feb; 38(1):56-8. PubMed ID: 19709780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
    Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ
    Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease--management of serogroup C clusters in a hyperendemic area.
    Dell E; Bedford D; McMahon B; Nicholson A
    Ir Med J; 2001 Jun; 94(6):166, 168-9. PubMed ID: 11495231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response.
    Houck P; Patnode M; Atwood R; Powell K
    Public Health Rep; 1995; 110(3):343-9. PubMed ID: 7610228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease.
    Memish ZA; Alrajhi AA
    Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global epidemiology of meningococcal disease.
    Harrison LH; Trotter CL; Ramsay ME
    Vaccine; 2009 Jun; 27 Suppl 2():B51-63. PubMed ID: 19477562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing epidemiology of meningococcal disease in the United States, 1992-1996.
    Rosenstein NE; Perkins BA; Stephens DS; Lefkowitz L; Cartter ML; Danila R; Cieslak P; Shutt KA; Popovic T; Schuchat A; Harrison LH; Reingold AL
    J Infect Dis; 1999 Dec; 180(6):1894-901. PubMed ID: 10558946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic meningococcal disease in the Norwegian Army].
    Djupesland P; Bjurne G; Aanonsen NO; Borchgrevink HM; Mundal R; Høiby EA
    Nord Med; 1990; 105(6-7):179-81. PubMed ID: 2367188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Healthy meningococcal carriers in 1973 in Greece. Sensitivity of the isolated strains to minocycline, rifampicin and sulphadiazine (author's transl)].
    Vassiliadis P; Patéraki E; Kalapothaki V; Trichopoulos D; Constantinidis E; Papadakis J
    Zentralbl Bakteriol Orig A; 1975; 230(2):159-71. PubMed ID: 807053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
    Khalil MK; Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL; van den Dobbelsteen GP; de Groot R
    Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual report of the Australian Meningococcal Surveillance Programme, 1999.
    Commun Dis Intell; 2000 Jul; 24(7):181-9. PubMed ID: 10981347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the epidemiology of cutaneous leishmaniasis in a young adult population in Israel: a long-term survey.
    Mimouni D; Balicer RD; Levine H; Klement E; Bar-Zeev Y; Davidovitch N; Zarka S
    Int J Dermatol; 2009 Jun; 48(6):611-3. PubMed ID: 19538370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.